Mandate

Vinge advises on transactions between Platzer and Länsförsäkringar

April 12, 2019 Private Equity

Vinge has advised Platzer Fastigheter in connection with the company’s entry into of an agreement with Länsförskringar Göteborg and Bohuslän concerning the transfer of half of the participating interests in the subsidiary with owns the property Gårda Vesta.

A building is currently being erected on the property which will include approximately 27 800 m2 of office space and will be completed in 2021. The parties have also entered into a lease agreement whereby Länsförsäkringar will rent 5 360 m2 of office space in Gårda Vesta. Since Länsförsäkringar is one of the largest shareholders in Platzer Fastigheter, the transaction was approved by the annual general meeting in 2018. The asset purchase agreement and lease agreement have been included in the same resolution adopted at the annual general meeting. As of the date of the annual general meeting, the property was valued at MSEK 1 300.

Vinge’s team primarily consisted of Olof Jisland, Assur Badur, Kristoffer Larson, Ulf Nilsson, Victor Ericsson and Nils Fredrik Dehlin.

Related

Vinge has advised Hansa Biopharma in connection with entering into a financing agreement

Vinge has advised Hansa Biopharma AB (publ), a commercial-stage biopharmaceutical company on a mission to develop and commercialize innovative, lifesaving and life-altering treatments for patients with rare immunological conditions, listed on Nasdaq Stockholm, in connection with a U.S. convertible note purchase agreement comprising USD 30 million aggregate principal amount of unsecured convertible senior notes.
March 23, 2026

Vinge advises in connection with data center provider EcoDataCenter’s tap issue of SEK 500 million bonds

Vinge has advised in connection with EcoDC Holding AB (publ)'s tap issue of SEK 500 million senior unsecured bonds under the existing framework of up to SEK 2 billion.
March 19, 2026

Vinge has advised Cinclus Pharma in connection with entering into financing agreement

Vinge has advised Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases listed on Nasdaq Stockholm, in connection with a long-term structured credit agreement for a total of up to EUR 28 million divided into four tranches, of which two are convertibles.
March 16, 2026